Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises IK Partners in the divestment of Carspect to TÜV SÜD
Mandate

Vinge advises IK Partners in the divestment of Carspect to TÜV SÜD

August 19, 2024 Banking and Finance M&A Financial Regulatory Real Estate and Construction Employment and Benefits Intellectual Property Commercial Agreements

Vinge has advised IK Partners and the other owners in connection with the divestment of Carspect Group Holding AB to TÜV SÜD Aktiengesellschaft. Carspect is a leading provider of vehicle inspections in Sweden, Estonia and Latvia, with a total of approximately 150 stations and over 500 employees.

Vinge's team consisted primarily of Jonas Bergström, Johanna Wiberg, Vilhelm Rondahl and Ida Appelgren (M&A), Lionardo Ojeda, Rebecka Margolin, Sofia Haggren and Nour Makie (Banking and Finance), ohan Cederblad (Permits & Accreditation), Kristoffer Larsson (Real Estate & Environment), Ebba Svenburg and Emil Lindwall (Employment Law), Martin Boström (Commercial Contracts / IT), Felizia Wiker (IP) and Anna Ekdahl Roos, Ellinore Boström Andersson and Gabriella Balbo (Transaction Support).

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025